Coronavirus (COVID-19) - Executive Briefing - July 22, 2021
In the week leading up to June 27, the US reported on average 39 cases per million population. Oklahoma, Nevada, and Missouri have reported an increase in new daily cases of more than 40% over the last 14 days. Cases in Brazil appear to have reached a plateau, with approximately 66,000 new daily cases reported in the 3 weeks leading up to June 27. However, there are concerns as 4.1 million Brazilians have not returned for their 2nd dose of the vaccine. This may lead to people requiring a first dose again. Recovery dates for Spain, and France remain unchanged, while recovery in the UK is delayed to October.
Complete outlook scenerio of COVID-19:
- Cases in Argentina remain high, with approximately 20,000 new daily cases reported in the 3 weeks leading up to June 27
- Cases in Colombia continue to increase, with 30,000 new daily cases reported during the week leading up to June 27
- Globally, the total number of single COVID-19 vaccine doses administered has exceeded the total number of people who have been infected with the virus since the pandemic began. Globally, the total number of single COVID-19 vaccine doses administered has exceeded the total number of people who have been infected with the virus since the pandemic began
- China has administered the most single doses of COVID-19 vaccines worldwide, followed by the US and India. However, the US has lost its position in the top 10 countries globally in the vaccination rate per 1000 population
- Gibraltar has administered the most single doses of COVID-19 vaccine per 1000 population worldwide, followed by the United Arab Emirates and Seychelles
- Gibraltar has the unusual distinction of vaccinating over 100% of its population most likely because it is administering doses to individuals who are traveling to Gibraltar for vacation or for work, but are not technically counted as residents, thus the vaccination rate can be 100%
Download our free report for more detailed insights on the scenario of COVID-19.
Have you explored all of our expert analysis? Uncover your next opportunity with our reports.
Access more premium companies when you subscribe to Explorer